FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Truist Securities analyst Gregg Gilbert lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $27.00 (from $28.00) while maintaining a Buy rating.... More

